BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 28739498)

  • 21. Management of Merkel cell carcinoma with emphasis on small primary tumors--a case series and review of the current literature.
    Tai P; Yu E; Assouline A; Lian JD; Kurian J; Krzisch C
    J Drugs Dermatol; 2010 Feb; 9(2):105-10. PubMed ID: 20214170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of Merkelcell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome.
    Haymerle G; Janik S; Fochtmann A; Pammer J; Schachner H; Nemec L; Mildner M; Houben R; Grasl MC; Erovic BM
    PLoS One; 2017; 12(8):e0180426. PubMed ID: 28763479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance.
    Lewis CW; Qazi J; Hippe DS; Lachance K; Thomas H; Cook MM; Juhlin I; Singh N; Thuesmunn Z; Takagishi SR; McEvoy A; Doolittle-Amieva C; Bhatia S; Paulson KG; O'Malley RB; Wang CL; Nghiem P
    Cancer Med; 2020 Feb; 9(4):1374-1382. PubMed ID: 31883234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 overexpression in head and neck cancer is related to lymph node metastasis.
    Nienstedt JC; Schroeder C; Clauditz T; Simon R; Sauter G; Muenscher A; Blessmann M; Hanken H; Pflug C
    J Oral Pathol Med; 2018 Mar; 47(3):240-245. PubMed ID: 29285811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Both tumor depth and diameter are predictive of sentinel lymph node status and survival in Merkel cell carcinoma.
    Smith FO; Yue B; Marzban SS; Walls BL; Carr M; Jackson RS; Puleo CA; Padhya T; Cruse CW; Gonzalez RJ; Sarnaik AA; Schell MJ; DeConti RC; Messina JL; Sondak VK; Zager JS
    Cancer; 2015 Sep; 121(18):3252-60. PubMed ID: 26038193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyltransferase-independent function of enhancer of zeste homologue 2 maintains tumorigenicity induced by human oncogenic papillomavirus and polyomavirus.
    Khattri M; Amako Y; Gibbs JR; Collura JL; Arora R; Harold A; Li MY; Harms PW; Ezhkova E; Shuda M
    Tumour Virus Res; 2023 Dec; 16():200264. PubMed ID: 37244352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Merkel cell carcinoma: histopathologic and prognostic features according to the immunohistochemical expression of Merkel cell polyomavirus large T antigen correlated with viral load.
    Leroux-Kozal V; Lévêque N; Brodard V; Lesage C; Dudez O; Makeieff M; Kanagaratnam L; Diebold MD
    Hum Pathol; 2015 Mar; 46(3):443-53. PubMed ID: 25623078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy for evaluation and treatment of patients with Merkel cell carcinoma: The Dana-Farber experience and meta-analysis of the literature.
    Gupta SG; Wang LC; Peñas PF; Gellenthin M; Lee SJ; Nghiem P
    Arch Dermatol; 2006 Jun; 142(6):685-90. PubMed ID: 16785370
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A better prognosis for Merkel cell carcinoma of unknown primary origin.
    Chen KT; Papavasiliou P; Edwards K; Zhu F; Perlis C; Wu H; Turaka A; Berger A; Farma JM
    Am J Surg; 2013 Nov; 206(5):752-7. PubMed ID: 23835211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic significance of ALCAM (CD166/MEMD) expression in cutaneous melanoma patients.
    Donizy P; Zietek M; Halon A; Leskiewicz M; Kozyra C; Matkowski R
    Diagn Pathol; 2015 Jul; 10():86. PubMed ID: 26134500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct Regulation of EZH2 and its Repressive H3K27me3 Mark in Polyomavirus-Positive and -Negative Merkel Cell Carcinoma.
    Durand MA; Drouin A; Mouchard A; Durand L; Esnault C; Berthon P; Tallet A; Le Corre Y; Hainaut-Wierzbicka E; Blom A; Saiag P; Beneton N; Bens G; Nardin C; Aubin F; Dinulescu M; Collin C; Fromont-Hankard G; Cribier B; Laurent-Roussel S; Cokelaere K; Houben R; Schrama D; Peixoto P; Hervouet E; Bachiri K; Kantar D; Coyaud E; Guyétant S; Samimi M; Touzé A; Kervarrec T
    J Invest Dermatol; 2023 Oct; 143(10):1937-1946.e7. PubMed ID: 37037414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of 15-lipoxygenase-1 in Merkel cell carcinoma is linked to advanced disease.
    Fochtmann-Frana A; Haymerle G; Schachner H; Pammer J; Loewe R; Kerjaschki D; Perisanidis C; Erovic BM
    Clin Otolaryngol; 2018 Oct; 43(5):1335-1344. PubMed ID: 29992788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Merkel cell carcinoma: 30-year experience from a single institution.
    Santamaria-Barria JA; Boland GM; Yeap BY; Nardi V; Dias-Santagata D; Cusack JC
    Ann Surg Oncol; 2013 Apr; 20(4):1365-73. PubMed ID: 23208132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LRIG1 is a positive prognostic marker in Merkel cell carcinoma and Merkel cell carcinoma expresses epithelial stem cell markers.
    Sundqvist B; Sihto H; von Willebrand M; Böhling T; Koljonen V
    Virchows Arch; 2021 Dec; 479(6):1197-1207. PubMed ID: 34331569
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.
    Wang Y; Chen Y; Geng H; Qi C; Liu Y; Yue D
    Tumour Biol; 2015 Sep; 36(9):7159-66. PubMed ID: 25877750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Value of TWIST1 and EZH2 Expression in Colon Cancer.
    Abdel Raouf SM; Ibrahim TR; Abdelaziz LA; Farid MI; Mohamed SY
    J Gastrointest Cancer; 2021 Mar; 52(1):90-98. PubMed ID: 31823218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcome of Combined Treatment of Surgery and Adjuvant Radiotherapy in Merkel Cell Carcinoma.
    Fiedler E; Vordermark D
    Acta Derm Venereol; 2018 Jul; 98(7):699-703. PubMed ID: 29379978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comprehensive review of the treatment of Merkel cell carcinoma.
    Eng TY; Boersma MG; Fuller CD; Goytia V; Jones WE; Joyner M; Nguyen DD
    Am J Clin Oncol; 2007 Dec; 30(6):624-36. PubMed ID: 18091058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p63 expression in Merkel cell carcinoma: comparative immunohistochemistry invokes TAp63 as the dominant isoform involved.
    Walsh NM; Saggini A; Pasternak S; Carter MD; Fleming K; Ly TY; Doucette S
    Hum Pathol; 2020 Mar; 97():60-67. PubMed ID: 31978504
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhancer of zeste homologue 2 (EZH2) expression in synovial sarcomas as a promising indicator of prognosis.
    Yalçınkaya U; Uğraş N; Özgün G; Ocakoğlu G; Deligönül A; Çetintaş SK; Bilgen MS
    Bosn J Basic Med Sci; 2017 Nov; 17(4):302-308. PubMed ID: 28738014
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.